Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy

IgA nephropathy is the most common primary glomerulonephritis and one of the leading causes of end-stage renal disease. We performed a randomized, controlled, prospective, open-label trial to determine whether leflunomide combined with low-dose corticosteroid is safe and effective for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Lulin, Wang, Qin, Cao, Liou, Zhou, Wenyan, Yuan, Jiangzi, Zhang, Minfang, Che, Xiajing, Mou, Shan, Fang, Wei, Gu, Leyi, Zhu, Mingli, Wang, Ling, Yu, Zanzhe, Qian, Jiaqi, Ni, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564655/
https://www.ncbi.nlm.nih.gov/pubmed/28415636
http://dx.doi.org/10.18632/oncotarget.16468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564655/
https://www.ncbi.nlm.nih.gov/pubmed/28415636
http://dx.doi.org/10.18632/oncotarget.16468

Ejemplares similares